CALR and Down syndrome: The immunoregulatory effect of LBP was further demonstrated by its ability to reduce serum levels of autoantibodies Sjogren’s-syndrome-related antigen A (SSA/Ro) and Sjogren’s-syndrome-related antigen B (SSB/La), thus alleviating autoimmune responses (32).